Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis

Romero, Rodrigo, Sayin, Volkan I, Davidson, Shawn M, Bauer, Matthew R, Singh, Simranjit X, LeBoeuf, Sarah E, Karakousi, Triantafyllia R, Ellis, Donald C +20 more·2017·Nature Medicine

DOI 10.1038/nm.4407

Cited by (664)

Items 401–500 of 664

Overcoming Resistance to Checkpoint Inhibitors with Combination Strategies in the Treatment of Non-Small Cell Lung Cancer
Amanda Reyes, Ramya Muddasani, Erminia Massarelli · 2024 · Cancers
NRF-mediated autophagy and UPR: Exploring new avenues to overcome cancer chemo-resistance
Sanaz Dastghaib, Sayed Mohammad Shafiee, Fatemeh Ramezani, Niloufar Ashtari, Farhad Tabasi, Javad Saffari‐Chaleshtori, Morvarid Siri, Omid Vakili, Somayeh Igder, Mozhdeh Zamani et al. · 2024 · European Journal of Pharmacology
Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathways
Hany M. Fayed, Gihan Farag Asaad, Marawan A. Elbaset, Ola A. Sharaf, Sawsan S. Mahmoud, Mohamed Mahmoud Amin, Zeinab A. El‐Gendy, Fatma A. Ibrahim, Sherein Saied. Abdelgayed, Rehab Fawzy Abdel-Rahman · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
Downregulation of the ubiquitin ligase KBTBD8 prevented epithelial ovarian cancer progression
Lei Du, Congrong Li, Qifeng He, Xiaohua Li, Linfei Yang, Yuan Zou, Zhi‐Xia Yang, Dong Zhang, Xiaowei Xing · 2020 · Molecular Medicine
Widely used gene editing strategies in cancer treatment a systematic review
Ahmed AbdulJabbar Suleiman, Walaa Yahya Saedi, Mohammed Jobair Muhaidi · 2020 · Gene Reports
Pathophysiological Potentials of NRF3-Regulated Transcriptional Axes in Protein and Lipid Homeostasis
Tsuyoshi Waku, Akira Kobayashi · 2021 · International Journal of Molecular Sciences
The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target—a narrative review
Alessia Spagnuolo, Paolo Maione, Cesare Gridelli · 2022 · Translational Lung Cancer Research
Prognostic value of KRAS G12C mutation in lung adenocarcinoma stratified by stages and radiological features
Hang Cao, Zelin Ma, Yuan Li, Yang Zhang, Haiquan Chen · 2023 · Journal of Thoracic and Cardiovascular Surgery
Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma
Sarah Neidler, Björn Kruspig, Kay D. Hewit, Tiziana Monteverde, Katarína Gyurászová, Attila Braun, William Andrew Clark, Daniel T. James, Ann Hedley, Bernhard Nieswandt et al. · 2019 · Cancers
Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy
Laura Torresano, Fulvio Santacatterina, Sonia Domínguez-Zorita, Cristina Nuevo‐Tapioles, Alfonso Núñez-Salgado, Pau B. Esparza‐Moltó, Lucía González-Llorente, Inés Romero-Carramiñana, Cristina Núñez de Arenas, Brenda Sánchez-Garrido et al. · 2022 · Oncogenesis
Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
Gina M. DeNicola, David B. Shackelford · 2021 · Cold Spring Harbor Perspectives in Medicine
A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options
Daniela Criscuolo, Francesco Morra, Angela Celetti · 2022 · Exploration of Targeted Anti-tumor Therapy
Rethinking our approach to cancer metabolism to deliver patient benefit
Saverio Tardito, Craig MacKay · 2023 · British Journal of Cancer
Regulation of Redox Homeostasis Through DNA/RNA Methylation and Post-Translational Modifications in Cancer Progression
Qiuchen Qi, Suli Yang, Juan Li, Peilong Li, Lutao Du · 2023 · Antioxidants and Redox Signaling
Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
Ichidai Tanaka, Junji Koyama, Hideyuki Itoigawa, Shunsaku Hayai, Masahiro Morise · 2023 · Frontiers in Oncology
Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors
Jyoti Dhar Malhotra, Subhajyoti De, Kim Nguyen, Percy P. Lee, Victoria Meucci Villaflor · 2024 · Cancer Immunology Immunotherapy
Modeling of Solid-Tumor Microenvironment in Zebrafish (Danio Rerio) Larvae
Yuxiao Yao, Lei Wang, Xu Wang · 2020 · Advances in experimental medicine and biology
CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges
Behrouz Shademan, Sepideh Masjedi, Vahidreza Karamad, Alireza Isazadeh, Fatma Söğütlü, Mohammad hosein saeedi rad, Alireza Nourazarian · 2022 · Biochemical Genetics
Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy
Margaret A. Potts, Jackson A. McDonald, Kate D Sutherland, Marco J. Herold · 2020 · European Journal of Immunology
Suppression of NRF2-dependent cancer growth by a covalent allosteric molecular glue
Nilotpal Roy, Tine L Wyseure, I‐Chung Lo, Justine Metzger, Christie L. Eissler, Steffen M. Bernard, Ilah Bok, Aaron Nathan Snead, Albert Parker, Jason C. Green et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Excess cysteine drives conjugate formation and impairs proliferation of NRF2-activated cancer cells
Jennifer A. Brain, Anna-Lena B.G. Vigil, Kristian Davidsen, Ayaha Itokawa, Abby C Jurasin, Hannah J. Kerbyson, Maximilian Kobiesa, Madeleine L. Hart, Sang Jun Yoon, Peter Bellotti et al. · 2026 · Nature Metabolism
AMPK-Mediated Phosphorylation of Nrf2 at S374/S408/S433 Favors Its βTrCP2-Mediated Degradation in KEAP1-Deficient Cells
Eleni Petsouki, Sylvia Ender, Shara Natalia Sosa Cabrera, Elke H. Heiß · 2023 · Antioxidants
Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside
Palma Fedele, Anna Natalizia Santoro, Francesca Pini, Marcello Pellegrino, Giuseppe Polito, Maria Chiara De Luca, Antonietta Pignatelli, Michele Tancredi, Valeria Lagattolla, Alessandro Anglani et al. · 2024 · Biology
A Core NRF2 Gene Set Defined Through Comprehensive Transcriptomic Analysis Predicts Selective Drug Resistance and Poor Multicancer Prognosis
George Luo, Harshita Kumar, Kristin Aldridge, Stevie Rieger, EunHyang Han, Ethan Jiang, Ernest Ricky Chan, Ahmed Soliman, Haider Mahdi, John J. Letterio · 2024 · Antioxidants and Redox Signaling
Dynamic regulation of the oxidative stress response by the E3 ligase TRIP12
Andrew J. Ingersoll, Devlon M. McCloud, Jane G. Hu, Michael Rapé · 2025 · Cell Reports
Iron–Sulfur Cluster Metabolism Impacts Iron Homeostasis, Ferroptosis Sensitivity, and Human Disease
Vladislav O. Sviderskiy, Erdem M. Terzi, Richard Possemato · 2019 · Springer eBooks
Identifying a locus in super-enhancer and its resident NFE2L1/MAFG as transcriptional factors that drive PD-L1 expression and immune evasion
Conglin Shi, Liuting Chen, Hui Pi, Henglu Cui, Chenyang Fan, Fangzheng Tan, Xuanhao Qu, Rong Sun, Fengbo Zhao, Yihua Song et al. · 2023 · Oncogenesis
Development of a mouse model expressing a bifunctional glutathione-synthesizing enzyme to study glutathione limitation in vivo
Rebecca C. Timson, Artem Khan, Beste Uygur, Marwa Saad, Hsi-wen Yeh, Nicole Lauren DelGaudio, Ross A. Weber, Hanan Alwaseem, Jing Gao, Chingwen Yang et al. · 2024 · Journal of Biological Chemistry
Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
Jacqueline V. Aredo, Sukhmani Kaur Padda · 2018 · Current Treatment Options in Oncology
Novel Therapeutics Affecting Metabolic Pathways
Salman Rafi Punekar, Daniel C. Cho · 2019 · American Society of Clinical Oncology Educational Book
Metabolic reprogramming and cancer precision medicine: a narrative review
Hong Zhang, Shuang Tang · 2021 · Precision Cancer Medicine
Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers
Nelly M. Dabbour, Ahmed M. Salama, Thoria Donia, Radwa T. Al-Deeb, Abdullah M. Abd Elghane, Karima H. Badry, Samah A. Loutfy · 2021 · Journal of Drug Delivery Science and Technology
Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs
Gavin R. McGivney, Qierra R. Brockman, Nicholas C. Borcherding, Amanda Scherer, Adam J. Rauckhorst, Wade R. Gutierrez, Shane R. Solst, Collin D. Heer, Akshaya Warrier, Warren Floyd et al. · 2025 · Science Advances
Oxygen needs sulfur, sulfur needs oxygen: a relationship of interdependence
Hiroki Sekine, Takaaki Akaike, Hozumi Motohashi · 2025 · The EMBO Journal
Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
Shenao Fu, Jiayao Ma, Changjing Cai, Jun Tan, Xiangying Deng, Hong Shen, Shan Zeng, Yihong Chen, Ying Han · 2025 · Journal of Experimental & Clinical Cancer Research
Suppression of the KRAS-NRF2 axis shifts arginine into the phosphocreatine energy system in pancreatic cancer cells
Eros Di Giorgio, Himanshi Choudhary, Annalisa Ferino, Ylenia Cortolezzis, Emiliano Dalla, Francesca D’Este, Marina Comelli, Valentina Rapozzi, Luigi Emilio Xodo · 2023 · iScience
Nrf-2-dependent antioxidant and anti-inflammatory effects underlie the protective effect of esculeoside A against retinal damage in streptozotocin-induced diabetic rats
Nasser A. Alsabaani, Kawther Faisal Amawi, Samy M. Eleawa, Wisam Nabeel Ibrahim, Walid Aldhaban, Ahmad M. Alaraj, Badr Alkhalaf, Waqas Sami, Hisham Alshaikhli, Mahmoud A. Alkhateeb · 2024 · Biomedicine & Pharmacotherapy
The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients
Manar Mikhail Atyah, Chenhao Zhou, Qiang Zhou, Wanyong Chen, Jialei Weng, Pengcheng Wang, Yi Shi, Qiongzhu Dong, Ning Ren · 2022 · International Journal of General Medicine
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
Ya-Chu Tang, Yung‐Jen Chuang, Hsin-Huei Chang, Shin‐Hun Juang, Gow‐Chin Yen, Jang-Yang Chang, Ching‐Chuan Kuo · 2023 · Journal of Food and Drug Analysis
NRF2 signaling and amino acid metabolism in cancer
Suji Ham, Bo-Hyun Choi, Mi‐Kyoung Kwak · 2024 · Free Radical Research
The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5
Man Zhao, Dalin Zhang, Haowen Jiang, Nishanth Kuganesan, Suchitra Natarajan, Leighton Pu, Kaushik N. Thakkar, Hongjuan Zhao, Quynh‐Thu Le, Amato J. Giaccia et al. · 2025 · Science Advances
The Landscape of Cancer Metabolism as a Therapeutic Target
Kenji Ohshima · 2025 · Pathology International
The genomic mutational landscape and its correlation with TMB, PD-L1 expression and CD8+ T cell infiltration in Chinese lung large cell neuroendocrine carcinoma
Ye Li, Xinying Shi, Beibei Mao, Lingxiong Wang, Lijia Wu, Jie Li, Shunchang Jiao · 2022 · Lung Cancer
Applications and advancements of CRISPR-Cas in the treatment of lung cancer
Lei Pan, Yixin Ju, Fenfen Peng, Jie Denny Luo · 2023 · Frontiers in Cell and Developmental Biology
DON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism
Ray Pillai, Thales Y. Papagiannakopoulos · 2023 · Cancer Research
Prediction of metabolites associated with somatic mutations in cancers by using genome-scale metabolic models and mutation data
GaRyoung Lee, Sang Mi Lee, Sungyoung Lee, Chang Wook Jeong, Hyojin Song, Sang Yup Lee, Hongseok Yun, Youngil Koh, Hyun Uk Kim · 2024 · Genome biology
STK11 and KEAP1 Mutations in Lung Adenocarcinoma: Solving the Puzzle Continues
Rafał Dziadziuszko · 2022 · Journal of Thoracic Oncology
Tumor Metabolic Heterogeneity
Marina V. Shirmanova, Snezhana D Sinyushkina, Anastasia D. Komarova · 2023 · Molecular Biology
Comprehensive strategies for constructing efficient CRISPR/Cas based cancer therapy: Target gene selection, sgRNA optimization, delivery methods and evaluation
Sathishbabu Paranthaman, Chinnappa A. Uthaiah, Shadab Md, Huda Mohammed Alkreathy · 2025 · Advances in Colloid and Interface Science
In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer
Lauren Brumage, Scott Best, Daniel S. Hippe, Eli Grunblatt, Pritha Chanana, Feinan Wu, Myung Chang Lee, Zhe Ying, Ali Ibrahim, Jae Heun Chung et al. · 2025 · Science Advances
KRAS and NRF2 drive metabolic reprogramming in pancreatic cancer cells: the influence of oxidative and nitrosative stress
Valentina Rapozzi, Clara Comuzzi, Eros Di Giorgio, Luigi Emilio Xodo · 2025 · Frontiers in Cell and Developmental Biology
Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new inhibitors
Donika Klenja-Skudrinja, Kevin X. Ali, David Walker, Maureen Higgins, Angana AH. Patel, Dorota Raj, Anna Creelman, Charlotte McDowall, Conor Taylor, Tomasz Wenta et al. · 2025 · Redox Biology
NRF2 activation in cancer and overview of NRF2 small molecule inhibitors
Hoang Hai Ngo, Bo-Yeong Yu, Jeong‐Eun Lee, Hyun Woo Kim, Young‐Sam Keum · 2025 · Archives of Pharmacal Research
Metabolic reprograming of antioxidant defense: a precision medicine perspective for radiotherapy of lung cancer?
Johann Matschke, Safa Larafa, Verena Jendrossek · 2021 · Biochemical Society Transactions
New insights into the mechanism of Keap1-Nrf2 interaction based on cancer-associated mutations
Liangkai Cheng, Huihui Wang, Shehan Li, Zhongqiu Liu, Caiyan Wang · 2021 · Life Sciences
Drosophila melanogaster behavior study: Does plumbum affect pupation and climbing ability of imago?
Diana Khoiroh, lin Hindun, Diani Fatmawati, Siti Zubaidah, Hendra Susanto, Ahmad Fauzi · 2023 · AIP conference proceedings
Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining
Junior Tayou · 2018 · Cellular Oncology
Will CRISPR-Cas9 Have Cards to Play Against Cancer? An Update on its Applications
Daisy Precilla Senthilathiban, Shreyas S. Kuduvalli, T. S. Anitha · 2021 · Molecular Biotechnology
Hyperprogressive disease with immunotherapy: new directions
Sally C. M. Lau, Natasha B. Leighl · 2019 · Journal of Thoracic Disease
Oncogenic Control of Metabolism
Natalya N. Pavlova, Craig B. Thompson · 2024 · Cold Spring Harbor Perspectives in Medicine
KRAS/PI3K axis driven GTF3C6 expression and promotes LUAD via FAK pathway
Xingzhao Ji, Mingqiang Liu, Tianyi Zhang, Weiying Zhang, Fuyuan Xue, Qiang Wan, Yi Liu · 2024 · Journal of Advanced Research
Crosstalk of glutamine metabolism between cancer-associated fibroblasts and cancer cells
Tingyu Chen, Yiming Xu, Fan Yang, Yanxin Pan, Ning Ji, Jing Li, Xin Ying Zeng, Qianming Chen, Lu Jiang, Yingqiang Shen · 2025 · Cellular Signalling
Decoding the NRF2–NOTCH Crosstalk in Lung Cancer—An Update
Angelo Sparaneo, Filippo Torrisi, Floriana D’Angeli, Giovanni Giurdanella, Sara Bravaccini, Lucia Anna Muscarella, Federico Pio Fabrizio · 2025 · Antioxidants
Oxidative stress in metastatic progression
Yoshifumi Ueda, Shigeki Kiyonaka, Yasuo Mori, Nobuaki Takahashi · 2025 · Trends in Cell Biology
SLC33A1 exports oxidized glutathione to maintain endoplasmic reticulum redox homeostasis
Shanshan Liu, Mark Gad, Caifan Li, Kevin Cho, Yuyang Liu, Khando Wangdu, Viktor Belay, Alon Millet, Hiroyuki Kojima, Henry Sanford et al. · 2026 · Nature Cell Biology
Impact of SARS-CoV-2 infection on immune cell cuproptosis in patients with lung adenocarcinoma via glutamine regulation
Dan Wang, Xijin Deng, Shanshan Li, Si Ri Gu Leng Sana · 2024 · International Immunopharmacology
Lymphatic Metastasis of Esophageal Squamous Cell Carcinoma: The Role of NRF2 and Therapeutic Strategies
Yahui Li, Zachary Ladd, Zhaohui Xiong, Candice Bui-Linh, Chorlada Paiboonrungruang, Boopathi Subramaniyan, Huan Li, Hai‐Ning Wang, Curt Balch, David Daniel Shersher et al. · 2025 · Cancers
Peptide 17, an inhibitor of YAP/TEAD4 pathway, mitigates lung cancer malignancy
Jirong Zhang, Yong Pan, Dehua Liao, Jingyi Tang, Dunwu Yao · 2018 · Tropical Journal of Pharmaceutical Research
Research on CRISPR/system in major cancers and its potential in cancer treatments
Zhengqiong Liu, Z. Liao, Yan Chen, Lihua Zhou, W. Huangting, H. Xiao · 2020 · Clinical & Translational Oncology
Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas
Thaise Nayane Ribeiro Carneiro, Larissa Valdemarin Bim, Vanessa Candiotti Buzatto, Vanessa Galdeno, Paula Fontes Asprino, Eunjung Alice Lee, Pedro A. F. Galante, Janete Maria Cerutti · 2021 · Cancers
Cytotoxic activity of KRAS inhibitors in combination with chemotherapeutics
Gerhard Hamilton, Adelina Plangger · 2021 · Expert Opinion on Drug Metabolism & Toxicology
NRF2-pathway mutations predict radioresistance in non-small cell lung cancer
Connor Jarrett Kinslow, Prashanth Kumar, Luke L. Cai, Ramon C. Sun, Kunal R. Chaudhary, Simon K. Cheng · 2022 · Translational Lung Cancer Research
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
Parneet Kaur Cheema, Shantanu Otto Banerji, Normand Blais, Quincy Siu-Chung Chu, Rosalyn Anne Juergens, Natasha B. Leighl, Adrian Gerold Sacher, Brandon S. Sheffield, Stephanie Leann Snow, Mark David Vincent et al. · 2023 · Current Oncology
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies
Sophia A. Wild, Ian Gordon Cannell, Katarzyna Kania, Ashley Nicholls, Dario Bressan, CRUK IMAXT Grand Challenge Team, Gregory J. Hannon, Kirsty Sawicka · 2022 · eLife
Patenting perspective on Keap1 inhibitors (2019–2024)
Yongfu Luo, Wenlong Yang, Yuan Zhang, Shutong Jiang, Jingyu Zhu, Xiangyang Li, Qidong You, Mengchen Lu · 2025 · Expert Opinion on Therapeutic Patents
Oncogenic NFE2L2 mutations in plasma ctDNA and tumors are predictors and prognosticators of chemoradiation therapy in resectable esophageal squamous cell carcinoma
Josephine Mun Yee Ko, Chen Guo, Alvin Ka-Kiu Leung, Steve Chun-Yin Chan, Anthony W.I. Lo, Lihua Tao, Hoi Yan Ng, Carissa Wing-Yan Wong, Simon Ying-Kit Law, Yhi Wong et al. · 2025 · British Journal of Cancer
NRF2 activation in cancer cells suppresses immune infiltration into the tumor microenvironment
Huaichun Wen, Takafumi Suzuki, Anqi Zhang, Miu Sato, Mahiro Matsumoto, Yuka Takahashi, Yushi Takahashi, Masayuki P. Yamamoto · 2025 · iScience
Oxidative Stress and DNA Epigenetic Modifications in Cancer: Mechanisms and Targeted Therapeutics
Xishan Yang, Qitai Chen, Yujie Yu, Yi Zang, Rujia Zheng, Zhe Zhang, Shuaijun Lu, Liwei Zhou · 2026 · MedComm – Oncology
Digital spatial profiling to predict recurrence in grade 3 stage I lung adenocarcinoma
Stephanie H. Chang, Valeria Mezzano, Hua Zhou, Andre Luis Moreira, Ray Pillai, Sitharam Ramaswami, Cynthia A. Loomis, Adriana Heguy, Aristotelis Tsirigos, Harvey Ira Pass · 2023 · Journal of Thoracic and Cardiovascular Surgery
Tumor evolution-targeted nanomedicineEVT
Lingpu Zhang, Jia‐Zhen Yang, Dongsheng Tang, Hanchen Zhang, Jianxun Ding, Haihua Xiao · 2022 · Scientia Sinica Chimica
Metabolic Heterogeneity of Tumors
Marina V. Shirmanova, Snezhana D Sinyushkina, Anastasia D. Komarova · 2023 · Molecular Biology
Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma
Maryam Yousefi, Laura Andrejka, Márton Szamecz, Monte M. Winslow, Dmitri A. Petrov, Gábor Zoltán Boross · 2023 · Proceedings of the National Academy of Sciences
Advances in Making Cancer Mouse Models More Accessible and Informative through Non-Germline Genetic Engineering
Katherine C. Murphy, Marcus A. Ruscetti · 2023 · Cold Spring Harbor Perspectives in Medicine
CRL2FEM1B uses heme to recruit BACH1 for degradation and regulate ferroptosis in lung cancer
Bashir Ahmed, Danièle Salaün, Jack B. Jordan, Avais M. Daulat, Chiara Pastorello, Tarcísio Brito, Yuying Yang, Emmanuelle Josselin, Deborah Byrne, S. Betzi et al. · 2026 · Molecular Cell
NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced glutathione synthesis
Ryan J. Conrad, James A. Mondo, Lingjue Wang, Peter S. Liu, Zijuan Lai, Feroza K. Choudhury, Qingling Li, Weng Ruh Wong, James Lee, Frances Shanahan et al. · 2025 · EMBO Reports
Dissecting the alternation landscape of mitochondrial metabolism-related genes in lung adenocarcinoma and their latent mechanisms
Xing Yu Jin, Di Liu, Demiao Kong, Xiaojiang Zhou, Liken Zheng, Xu Chuan · 2023 · Aging
Sphingosine 1‐phosphate combining with S1PR4 promotes regulatory T cell differentiation related to FAO through Nrf2/ PPARα
Rui Feng, Chuang Liu, Zilin Cui, Zirong Liu, Yamin Zhang · 2023 · Scandinavian Journal of Immunology
Novel allosteric glutaminase inhibitors with macrocyclic structure activity relationship analysis (part 2)
Eun Ji Lee, Jiyoon Jang, Rajath Cyriac, Mi Ran Yun, Yeongju Kwon, Myoung Eun Jung, Gildon Choi, Chong Hak Chae, Byoung Chul Cho, Kwang‐Ho Lee · 2024 · Bulletin of the Korean Chemical Society
Mechanisms and Markers of Clinical Radioresistance
Michael Sargent Binkley, Maximilian Diehn, Iris Eke, Henning Willers · 2020 · Cancer drug discovery and develogment/Cancer drug discovery and development
RAS: Circuitry and therapeutic targeting
Gagandeep Singh, Neelam Thakur, Umesh Kumar · 2022 · Cellular Signalling
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth
Ali Rashidfarrokhi, Ray Pillai, Hao Yuan, Warren Wu, Burcu Karadal-Ferrena, Sofia G. Dimitriadoy, Michael J Cross, Anna H. Yeaton, Shih Ming Huang, Arjun J. Bhutkar et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Therapeutic potential of canagliflozin in DEN/TAA-induced renal cancer: mechanistic insights into NLRP3/IL-6/STAT3 and AMPK signaling and oxidative stress regulation
Rehab Fawzy Abdel-Rahman, Mahdi H. Alsugoor, Naif Alsuhaymi, Hany M. Fayed, Sawsan S. Mahmoud, Fatma A. Ibrahim, Marawan A. Elbaset · 2025 · Saudi Pharmaceutical Journal
Depletion-dependent activity-based protein profiling using SWATH/DIA-MS detects serine hydrolase lipid remodeling in lung adenocarcinoma progression
Tatjana Sajic, Matej Vizovišek, Stephan Arni, Rodolfo Ciuffa, Martin Mehnert, Sébastien Lenglet, Walter Weder, Héctor Gallart‐Ayala, Julijana Ivanišević, Marija Buljan et al. · 2025 · Nature Communications
Involvement of KEAP1 / NRF2 pathway in non‐ BRAF mutated squamous cell carcinoma of the thyroid
Elin Schoultz, Jakob Dahlberg, Lisa M. Nilsson, Jozefina J. Dzanan, Therese Carlsson, Niklas Dahr, Ellinor Andersson, Ghayeb Muhammad, Andreas Muth, Erik Elias et al. · 2025 · The Journal of Pathology
Beyond the Tissue: Unlocking NSCLC Treatment Potential Through Liquid Biopsy
Milica Kontić, Mihailo Stjepanović, Filip Marković · 2025 · Genes
Repurposing approved drugs as ferroptosis modulators: a critical review of clinical trials in cancer and neurodegeneration
Mohammed Zayed, Ahmed Massoud, Enas Elwakeel, Prehan Ezzat, Yaser Alammar, Nessma A. Abd El-Wahab, Rahma W. Afifi, Byung‐Hoon Jeong · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC
Michelle Shiller, Melissa Lynne Johnson, Robert Auber, Sandip Pravin Patel · 2024 · Frontiers in Oncology
Metabolic Reprogramming and Molecular Rewiring in Cancer: Therapeutic Opportunities
Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya · 2021 · The Indonesian Biomedical Journal
Non-canonical genomic driver mutations of urethane carcinogenesis
Siqi Li, Christopher M. Counter · 2022 · PLoS ONE
Metabolic cancer therapy: proof of concept
V.A. Chubenko, V.М. Moiseyenko · 2022